| 2 weeks ago - International Sales Account Manager Autoscribe Informatics - Reading, Berkshire RG7 8DA
Autoscribe Informatics is looking for an International Sales Account Manager to join our friendly Technical Sales team within a fast growing software company. For a...
4 weeks ago - Medical Laboratory Tech KurzSolutions - Acoma, NM 87034
Medical Laboratory TechnologistThe Sky CityThe Community – Acoma PuebloAcoma Pueblo is regarded as the oldest continuously inhabited community in the United States. Access to the...
1 month ago - Programmer Analyst II (Dallas Water) (LIMS Administrator) City of Dallas - Dallas, Texas 75201
Programmer Analyst II (Dallas Water) (LIMS Administrator) An Equal Opportunity Employer SALARY $26.55 – $38.46 Hourly $2,123.92 – $3,076.69 Biweekly $55,222.00 –... | 
A major research-based biopharmaceutical company was working with a commercial LIMS vendor to implement a LIMS for the Biometrics department. Both the biopharmaceutical company and the LIMS vendor had project teams which interfaced closely to move the project forward. 
The concept behind the Strateos SmartLab Platform is to serve as a vehicle to propel drug discovery innovations to new heights of speed and efficiency to get life-saving medicines to patients faster. 
Many people in the laboratory industry will have heard of Autoscribe Informatics and its Laboratory Information Management System (LIMS) solution, Matrix Gemini. Autoscribe celebrates 40 years in business this year, making it one of the earliest suppliers of LIMS. 
Noting a dearth of published research on "cannabinoid and terpenoid profiles in different hemp phenotypes within the same variety," Eržen et al. of the Slovenian Institute of Hop Research and Brewing and the University of Ljubljana took matters into their own hands and conducted such a study. The researchers examined 11 phenotypes from three different Cannabis varieties: Carmagnola Selected (CS), Tiborszallasi (TS), and Finola Selection (FS). Their objective? They intended "to establish a connection between the chemical composition and morphological characteristics of hemp plants and to identify phenotypes with an interesting ratio between cannabinoids for further pharmaceutical applications." After providing background and reasoning for selecting their varieties, the authors discuss the results of their chemical analyses as well as the materials and methods they used. The authors conclude by summarizing their findings, including specific phenotypes that could be prime targets for further cannabis pharmaceutical research. 
This is an advanced University of British Columbia-created course that is released on the edX platform. The scheduled six-week course is designed to help learners to better understand 'international best practices for biobanking and research involving human biospecimens, based on National Cancer Institute (NCI) and International Society of Biological Environmental Repositories standards (ISBER)." The course is $99 and presumably comes with a certificate of completion. The course requires on average four to five hours a week of effort. Access to the class begins September 22, 2020.
